Avacta Group advances Phase 1 trial of oncology drug candidate AVA6000
Avacta Group plc (AIM: AVCT), a prominent life sciences company, has achieved a significant milestone in its Phase 1 clinical trial for AVA6000, a novel ... Read More
Nordson EFD launches advanced GVPlus and PROX automated fluid dispensing solutions
Nordson EFD, a subsidiary of Nordson Corporation (NASDAQ: NDSN) and a frontrunner in the manufacture of precision fluid dispensing systems, has unveiled its latest advancements ... Read More
Avacta Group reports promising early results for Phase 1a study of AVA6000
Avacta Group plc (AIM: AVCT), a leading life sciences company dedicated to developing innovative oncology drugs and powerful diagnostics, has announced a crucial milestone in ... Read More